The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.
- Investigator
- Hans K Ghayee
- Status
- Accepting Candidates
- Ages
- 18 Years - 74 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Pheochromocytoma , 24 publications
- Adrenal Gland Neoplasms , 23 publications
- Paraganglioma , 21 publications
- Succinate Dehydrogenase , 12 publications
Research activity
Active clinical trials
My publications
Filter publications
72 publications
2026
Pheochromocytomas and Paragangliomas.
Endocrinology and metabolism clinics of North America
PubMed • Publisher's site2026
Targeted lipidomics between hPheo1 and SDHB KD cells reveal changes in bioactive lipids and PKC with polyamine pathway inhibition
Physiological Reports
Publisher's site2026
The Biochemical Spectrum of Pheochromocytoma.
Journal of investigative medicine high impact case reports
PubMed • Publisher's site2026
BUB1 as a candidate non-oncogene addiction vulnerability in metastatic phaeochromocytoma/paraganglioma.
Scientific reports
PubMed • Publisher's site2025
CBD Disrupts Malme-3M Cell Metabolism via Glycolytic Shift and Redox Imbalance.
Current issues in molecular biology
PubMed • Publisher's site